Quest Diagnostics, Inc. DGX

NYS: DGX | ISIN: US74834L1008   21/09/2026
244,88 USD (-0,64%)
(-0,64%)   21/09/2026

21 september 2026 · Nearly 1 in 3 Patients with Suspected Lyme Disease are Co-Positive for Other Tick-Borne Pathogens, Finds Study by Quest Diagnostics · Persbericht

16 september 2026 · Nine in 10 Voters Express Concern That Medicare Lab Payment Cuts Will Harm Patient Access to Diagnostic Lab Testing, Finds National Survey from Quest Diagnostics · Persbericht

9 september 2026 · Apple Health app Users to be Able to Order Labs from Quest Diagnostics · Persbericht

25 augustus 2026 · Humanity propose l'analyse de l'âge biologique aux États-Unis via questhealth.com · Persbericht

25 augustus 2026 · Quest Diagnostics to Speak at the Baird 2026 Global Healthcare Conference · Persbericht

25 augustus 2026 · Humanity Brings Biological Age Analysis to the U.S. Through questhealth.com · Persbericht

24 augustus 2026 · Quest Diagnostics to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference · Persbericht

24 augustus 2026 · Quest Diagnostics to Offer FDA-Cleared Roche pTau217 Blood Test to Assess Alzheimer's Disease Pathology · Persbericht

12 augustus 2026 · Quest Diagnostics Declares Quarterly Cash Dividend · Persbericht

30 juli 2026 · Bacterial Vaginosis Linked to Increased STI Co-Infection, Finds National Study of 1.5 Million Women from Quest Diagnostics · Persbericht

23 juli 2026 · Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026 · Persbericht

10 juli 2026 · One in Five American Workers Tested Had a Positive Hair Drug Test in 2025, Signaling Persistent Long-Term Substance Use Patterns · Persbericht

8 juli 2026 · Quest Diagnostics Now the Largest Clinical Reference Lab to Extend Oncology Test Access Through OncoEMR MPI · Persbericht

24 juni 2026 · Quest Diagnostics Receives New York State Approval for Haystack MRD®, Broadening Patient Access to ctDNA Minimal Residual Disease Testing · Persbericht

18 juni 2026 · UTI-causing Bacteria Resistant to Current Drugs, Finds National Study by Hackensack Meridian CDI and Quest Diagnostics · Persbericht

17 juni 2026 · Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026 · Persbericht

16 juni 2026 · Quest Diagnostics Unveils Achievements in Healthcare Access, Employee Engagement and Environmental Sustainability in 2025 Corporate Responsibility Report · Persbericht

19 mei 2026 · Quest Diagnostics Declares Quarterly Cash Dividend · Persbericht

27 april 2026 · Quest Diagnostics Prices $500 Million of Senior Notes · Persbericht

21 april 2026 · Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026 · Persbericht

Mijn selecties